![DA 1686](/ProductImageEN1/2024-11/Large/aaef1103-66c8-498b-ae85-0b88ec76fd39.png)
DA 1686 NEW
Price | $1520 | $1980 | $2500 |
Package | 25mg | 50mg | 100mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-19 |
Product Details
Product Name: DA 1686 | CAS No.: 13071-27-7 |
Supply Ability: 10g | Release date: 2024/11/19 |
Product Introduction
Bioactivity
Name | DA 1686 |
Description | DA 1686 is a therapeutic antiarrhythmic compound.DA 1686 reduces the tachycardic effects of aconitine. It also reduces the effects of increased frequency of electrical stimulation and is 1.8 times more active than quinidine and 9 times more active than procainamide. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | BRN1029299 | BRN-1029299 | DA 1686 |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/200kg |
VIP1Y
|
Qingdao RENAS Polymer Material Co., Ltd.
|
2024-10-28 | |
$898.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$0.00/1KG |
VIP3Y
|
Shanghai Qyubiotech Co., Ltd.
|
2023-11-08 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hills
INQUIRY